Product correctly added to cart.

discount label
PF-4800567
View 3D

Biosynth logo

PF-4800567

CAS: 1188296-52-7

Ref. 3D-NXB29652

25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
PF-4800567
Description:

PF-4800567 is a small molecule that inhibits the activity of β-catenin, a protein that plays an important role in the regulation of cell growth and differentiation. This drug has been shown to have minimal toxicity in animals and has been used as a chemical biology tool for the study of β-catenin function. PF-4800567 is also being developed as a potential treatment for bladder cancer. In animal models, this drug has shown efficacy in reducing tumor size and increasing survival rates. The compound also inhibits the growth of t-cell lymphomas by blocking β-catenin signaling pathways. PF-4800567 has shown efficacy as an inhibitor of locomotor activity in mice and can be used to study metabolic disorders such as diabetes. This compound may also be useful for treating autoimmune diseases due to its ability to suppress immune responses.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
359.81 g/mol
Formula:
C17H18ClN5O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-NXB29652 PF-4800567

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".